🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has removed problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at home.

Within moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Costs

Inside these groups, posts display dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram stated it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially significant health risks”.